"You got to love CSL's PE ratio. 42 ish. Love it. Good to know the sector can have these ratios."
@tota1999,
Mmmmm.
What I'm not loving so much is your valuation arithmetic that has led you to derive a P/E multiple of 42x.
I suspect you are combining CSL's profits - which are reported in US dollars - with CSL's ASX share price - which is quoted in Australian dollars.
Don't feel bad, though. It's a perfectly understandable rookie error.
PS. In which year do you think MSB will have an "E" which the market will be able to capitalise via a P/E in order to arrive at a valuation (instead of all this guessing that occurs, the result of which is a highly volatile share price)? 2018? 2019? 2020?
- Forums
- ASX - By Stock
- MSB
- MSB as "the Next CSL"
MSB as "the Next CSL", page-5
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B |
Open | High | Low | Value | Volume |
$1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 5440 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | 1.460 |
2 | 19558 | 1.455 |
5 | 49977 | 1.450 |
5 | 102249 | 1.445 |
2 | 30389 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 5440 | 3 |
1.470 | 22187 | 2 |
1.475 | 84389 | 3 |
1.480 | 118230 | 9 |
1.485 | 96793 | 8 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online